You may have to Search all our reviewed books and magazines, click the sign up button below to create a free account.
At the workshop held in Leverkusen on December 1, 1993, Professor Dr. Stanislav Kazda was honored on the occasion of his retirement for his scientific contributions and his involvement in drug development in our company, Bayer AG. In a recent article by Eugene Garfield (Current ContentslLife Sciences 36:3-15, 1993), what most of us participating in this workshop have supposed for years was confirmed: that Kazda is one of the leading scientific authors in academia worldwide. In the said survey of citations of biomedical research articles, Kazda is number 29 in terms of actual impact, individual ~itations, and total number of published manuscripts (and this only covers the time period from 198...
First multi-year cumulation covers six years: 1965-70.
This volume reviews important milestones in the history of the development of 1,4-dihydropyridines starting in the late 1960s. The discovery led to theestablishment of Ca2+ antagonists as leading cardiovascular drugs throughoutthe world. This volume includes presentations of the results of some recent collaborative extramural studies by American investigators.
None